» Authors » L Patrone

L Patrone

Explore the profile of L Patrone including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 140
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gadenne V, Grenier B, Praveen C, Marsal P, Valmalette J, Patrone L, et al.
Phys Chem Chem Phys . 2019 Nov; 21(46):25865-25871. PMID: 31737870
Having clear and deep information on the surface/interface of deposited molecules is of crucial importance for the development of efficient optoelectronic devices. This paper reports on a joint experimental/theoretical hybrid...
2.
Pardanaud C, Merlen A, Gratzer K, Chuzel O, Nikolaievskyi D, Patrone L, et al.
J Phys Chem Lett . 2019 Jun; 10(13):3571-3579. PMID: 31198044
We report on an alternative route based on nanomechanical folding induced by an AFM tip to obtain weakly interacting multilayer graphene (wi-MLG) from a chemical vapor deposition (CVD)-grown single-layer graphene...
3.
Rossi U, Petrocelli F, Seitun S, Patrone L, Ferro C
Radiol Med . 2012 Oct; 118(3):356-65. PMID: 23090246
Purpose: We evaluated technical success, safety and effectiveness of percutaneous radiological gastrostomy (PRG) with a modified technique: single puncture and double anchor. Materials And Methods: From January 2008 to June...
4.
Delafosse G, Merlen A, Clair S, Patrone L
J Chem Phys . 2012 May; 136(19):194704. PMID: 22612106
P-aminothiophenol (PATP) is a well-known molecule for the preparation of self-assembled monolayers on gold via its thiol functional group. After adsorption, it has been demonstrated that this molecule is anchored...
5.
Valentino L, Mamonov V, Hellmann A, Quon D, Chybicka A, Schroth P, et al.
J Thromb Haemost . 2012 Jan; 10(3):359-67. PMID: 22212248
Background: Prophylaxis with factor (F)VIII is considered the optimal treatment for managing hemophilia A patients without inhibitors. Objectives: To compare the efficacy of two prophylaxis regimens (primary outcome) and of...
6.
Bjorkman S, Blanchette V, Fischer K, Oh M, Spotts G, Schroth P, et al.
J Thromb Haemost . 2010 Apr; 8(4):730-6. PMID: 20398185
Background: Dose tailoring of coagulation factors requires reliably estimated and reproducible pharmacokinetics (PK) in the individual patient. Objectives: To investigate the contribution of both biological and methodological factors to the...
7.
Merlen A, Gadenne V, Romann J, Chevallier V, Patrone L, Valmalette J
Nanotechnology . 2009 May; 20(21):215705. PMID: 19423944
Aggregates of Au nanoparticles have been extremely easily obtained on glass substrates by physical sputtering under primary vacuum. With such a protocol, we demonstrate that it is possible to control...
8.
Patrone L, Palacin S, Charlier J, Armand F, Bourgoin J, Tang H, et al.
Phys Rev Lett . 2003 Oct; 91(9):096802. PMID: 14525200
The transport properties of two oligothiophene derivatives, that differ only by the chemical group coupling to gold, are compared. It is shown that the role of the coupling group in...
9.
Malone C, Patrone L, Wall R
Mol Immunol . 2000 Sep; 37(6):321-8. PMID: 11000405
The mb-1 (Igalpha) gene is B cell-specific and expressed throughout B cell maturation. In combination with B29 (Igbeta) and surface immunoglobulin mb-1 comprises the B cell receptor complex (BCR). The...
10.
Malone C, Patrone L, Buchanan K, WEBB C, Wall R
J Immunol . 2000 Feb; 164(5):2550-6. PMID: 10679093
The B cell-specific B29 (Igbeta) gene is activated in the earliest B cell precursors and is expressed throughout B cell development. Tissue-specific expression of the murine B29 gene is controlled...